Skip to content

AKEBIA THERAPEUTICS, INC.

AKBA

CIK 0001517022

← back to feed
Revenue (TTM)
$232.12M
+47.5% YoY Q1 May 2026
Net Income (TTM)
−$2.16M
+92.3% YoY Q1 May 2026
EPS Diluted (TTM)
$0.00
+93.9% YoY Q1 May 2026
Gross Margin
83.1%
Q1 May 2026
Operating Margin
11.8%
Q1 May 2026
Net Margin
-0.9%
Q1 May 2026
Free Cash Flow (TTM)
−$71.85M
Q1 May 2026
Cash
$162.64M
Q1 May 2026
Total Debt
$48.89M
Q1 May 2026
Shares Outstanding
268.26M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings